During the past decade, The Centers for Vulvovaginal Disorders conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Centers for Vulvovaginal Disorders" #1 collaborator was "Gynecologic Cancer Research Foundation" with 2 trials as a collaborator, "El. En. SpA" with 1 trials as a collaborator, "EndoCeutics Inc." with 1 trials as a collaborator, "George Washington University" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Centers for Vulvovaginal Disorders" are "Lichen Sclerosus" (3 trials), "Vulvodynia" (2 trials), "Dyspareunia" (1 trials), "Genitourinary Syndrome of Menopause" (1 trials) and "Hypoactive Sexual Desire Disorder" (1 trials). Many other conditions were trialed in "The Centers for Vulvovaginal Disorders" in a lesser frequency.

Most popular intervention types in "The Centers for Vulvovaginal Disorders" are "Drug" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Botulinum toxin type A" (1 trials), "FxCO2 Laser" (1 trials), "Intrarosa" (1 trials) and "Placebos" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Centers for Vulvovaginal Disorders" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "The Centers for Vulvovaginal Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Centers for Vulvovaginal Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Centers for Vulvovaginal Disorders, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".